Listing 1 - 10 of 21 | << page >> |
Sort by
|
Choose an application
Choose an application
L'année 2010 annonce un grand changement dans le mode de rémunération du pharmacien d'officine. Depuis maintenant quelques années les différents acteurs du système de délivrance et de remboursement des médicaments travaillent ensemble pour définir les modalités de ce nouveau système de rémunération entré en vigueur ce 1er avril Un système qui aura pour vocation d'une part protéger le pharmacien contre l'évolution d'un marché sur laquelle il n'a que peu de prise et d'autre part de valoriser l'exercice du pharmacien en le rémunérant pour sa valeur ajoutée à la délivrance de médicaments. L'objet de ce mémoire est de décrire cette évolution pour illustrer dans quelle mesure ce nouveau système de rémunération pourra remplir son rôle. La première partie du mémoire sera consacrée à l'étude de l'évolution du marché et du paysage officinal belge. Nous y aborderons des sujets comme les caractéristiques de la population officinale, la répartition des pharmacies, l'évolution et la composition du chiffre d'affaire des officines et d'autres sujets illustrant la nécessité de changer le mode de rémunération des pharmaciens. La seconde partie aura pour objet la description de ce nouveau système. Une description exhaustive de ce nouveau système pourrait constituer à elle seule le volume d'un mémoire. Pour cette raison, afin de limiter le volume de ce présent mémoire, cette seconde partie sera plus axée sur la mise en place de ce système et la justification de ces nouvelles honoraires plutôt que sur la description pure et dure des composantes de ce système
Pharmacists --- Salaries and Fringe Benefits --- Reimbursement Mechanisms
Choose an application
The paradigm of personalized medicine is an emerging topic, triggering some specific legal and ethical challenges as regards data collection, sharing and use, informed consent, privacy and public trust, and the changing status of patients and social equality. These legislative developments and challenges have been discussed in light of the Finnish and the common-European experiences. During recent years, the Finnish legislative processes aiming at generating ‘innovation-friendly’ legislation for scientific research purposes as well as integrating genomic research results into the clinical setting have been heavily challenged by rapid developments in technology and medicine. In particular, there is a need to pursue the right balance between scientific and commercial interests, public health, and individual rights. We aim at providing insights into the legislative processes surrounding personalized medicine with a special focus on how the freedom of science, equitable access to healthcare, public health, and commercial issues that must be balanced with individual rights as expressed in the EU Charter and the Council of Europe’s Oviedo Convention on Human Rights and Biomedicine.
Biomedical research --- Gene editing --- Legislation, Medical --- Reimbursement mechanisms --- Biomedical Research. --- Gene Editing. --- Legislation, Medical. --- Reimbursement Mechanisms.
Choose an application
Costs and Cost Analysis --- Economics, Hospital --- Patients --- Reimbursement Mechanisms --- methods --- classification
Choose an application
Costs and Cost Analysis --- Economics, Hospital --- Patients --- Reimbursement Mechanisms --- methods --- classification
Choose an application
Hospitals --- Diagnosis-Related Groups --- Medicare --- Reimbursement Mechanisms --- Planning --- Prospective payment --- Rates --- economics
Choose an application
Hospitals --- Medical fees. --- Hospital care --- Cost Control --- Quality of Health Care --- Reimbursement Mechanisms --- Rates. --- Cost effectiveness. --- methods. --- economics --- Medicare.
Choose an application
WM 105 Clinical psychology. Mental health --- Belgium --- Reimbursement Mechanisms --- Healthcare Financing --- Organisation and Administration --- Health Policy --- Psychology
Choose an application
En tant quorganisme assureur, nous nous devons dassurer une accessibilité optimale à nos affiliés, des soins de santé de qualité et développer des initiatives, créatives et innovantes, en matière de promotion de la santé. Pour y parvenir, lanalyse de la consommation médicale et de ses déterminants est fondamentale.
Choose an application
Reimbursement Mechanisms. --- Prospective Payment System. --- Delivery of Health Care --- Drug Utilization --- Formularies as Topic. --- Drugs, Essential --- Adjustment, Discretionary --- Discretionary Adjustment Factor --- Prospective Pricing --- Prospective Reimbursement --- Reimbursement, Prospective --- Adjustment Factor, Discretionary --- Adjustment Factors, Discretionary --- Adjustments, Discretionary --- Discretionary Adjustment --- Discretionary Adjustment Factors --- Discretionary Adjustments --- Factor, Discretionary Adjustment --- Factors, Discretionary Adjustment --- Payment System, Prospective --- Payment Systems, Prospective --- Pricing, Prospective --- Prospective Payment Systems --- Prospective Reimbursements --- Reimbursements, Prospective --- System, Prospective Payment --- Systems, Prospective Payment --- Mechanism, Reimbursement --- Mechanisms, Reimbursement --- Reimbursement Mechanism --- economics. --- Theses --- Reimbursement mechanisms --- PROSPECTIVE PAYMENT SYSTEM --- DELIVERY OF HEALTH CARE --- DRUG UTILIZATION --- Formularies --- economics --- Reimbursement mechanisms. --- PROSPECTIVE PAYMENT SYSTEM. --- Formularies. --- Delivery of health care --- Drug utilization --- Prospective payment system. --- Economics. --- Reimbursement Mechanisms --- Prospective Payment System --- Formularies as Topic
Listing 1 - 10 of 21 | << page >> |
Sort by
|